About 100 reports

  • MUSCULOSKELETAL DISORDERS THERAPEUTICS MARKET IN AMERICAS
  • MUSCULOSKELETAL DISORDERS THERAPEUTICS MARKET IN APAC

About Musculoskeletal Disorders Musculoskeletal disorders are the group of pain disorders or injuries that affect the body's joints, muscles, nerves, ligaments, tendons, and structures, all of which support the hands, legs, neck and back. The pain and discomfort vary with the severity of the condition. These disorders have a wide range...

  • Musculoskeletal Disorder
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • Eli Lilly & Co.

Musculoskeletal Disorders Drugs Global Market Report 2018 ##.

  • Chronic Disease
  • Musculoskeletal Disorder
  • Pathology
  • World
  • MUSCULOSKELETAL DISORDERS DRUGS
  • GLOBAL MUSCULOSKELETAL DISORDERS DRUGS MARKET, SEGMENTATION BY SUBSEGMENT

The pharmaceutical industry develops drugs to diagnose, cure, treat or prevent diseases.Pharmaceutical companies produce both generic and branded drugs. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing. Pharmaceutical drugs are intended for human or...

  • Musculoskeletal Disorder
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.

SUMMARY: - Musculoskeletal Disorders Pipeline by Indication - Musculoskeletal Disorders Pipeline by Clinical Trial Phase - Musculoskeletal Disorders Pipeline by Drug Mechanism Classes - Musculoskeletal Disorders Pipeline by Comp

  • Chronic Disease
  • Musculoskeletal Disorder
  • Pathology
  • World
  • Market Description
  • Musculoskeletal Drugs Market Forecast Growth
  • Musculoskeletal Drugs Market Historic Growth

The musculoskeletal system drugs market comprises companies that discover, develop, manufacture and distribute medications used in the treatment of musculoskeletal diseases. Musculoskeletal diseases include arthritis, osteoporosis, osteomalacia, carpal tunnel syndrome, tendonitis, rotator cuff tear, muscular dystrophy, myasthenia gravis, lupus...

  • Musculoskeletal Disorder
  • World
  • Forecast
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • 6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS

Physiotherapy Equipment Market The market for the period 2015-2020 is expected to account for $XX billion at a CAGR of XX% from $XX billion on 2014. Physiotherapy is a form of physical therapy that uses various procedures and equipment to ease pain ailments. Physiotherapy forms an essential part of rehabilitation in post-surgery,...

  • Musculoskeletal Disorder
  • World
  • Demand
  • Market Segment
  • Market Size
  • 7.1 BIBLIOGRAPHY

Epidemiology of rheumatic musculoskeletal disorders in the developing world.

  • Musculoskeletal Disorder
  • Market Size
  • Beckman Coulter, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlobalData's company
  • Osteoporosis Therapeutics Market, Global, All Pipeline Products, Discovery,

Osteoporosis Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies Summary Osteoporosis, the most common metabolic bone disease, is characterized by low bone mass, microarchitectural deterioration of bone tissue, and a consequent increase...

  • Musculoskeletal Disorder
  • World
  • Market Size
  • Amgen Inc.
  • Merck & Co., Inc.

Wyeth has a long history of pioneering developments in pharmaceuticals and biotechnology, with leading products in the areas of women' s health care, neuroscience, musculoskeletal disorders, vaccines and infectious disease, hemophilia, and oncology.

  • Musculoskeletal Disorder
  • China
  • Demand
  • Bayer AG
  • Yunnan Baiyao Group Co., Ltd.

You can easily book an appointment with one online.

  • Musculoskeletal Disorder
  • United States
  • Asterias Biotherapeutics, Inc.
  • BioTime, Inc.
  • OrthoCyte Corporation

Wyeth has a long history of pioneering developments in pharmaceuticals and biotechnology, with leading products in the areas of women' s health care, neuroscience, musculoskeletal disorders, vaccines and infectious disease, hemophilia, and oncology.

  • Musculoskeletal Disorder
  • China
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.
  • 12.1 INTRODUCTION

IN INDIA, ##% OF THE OVERALL POPULATION SUFFERS FROM AILMENTS RELATED TO MUSCULOSKELETAL DISORDERS (MSD).

  • Musculoskeletal Disorder
  • Forecast
  • Market Size
  • Smith & Nephew Plc
  • Zimmer Biomet Holdings, Inc.
  • 4.1 BIBLIOGRAPHY

BMC Musculoskeletal Disorders; ##(##): ##.

  • Musculoskeletal Disorder
  • Japan
  • Spain
  • United States
  • Forecast
  • Vendor landscape

FROBEN IS INDICATED TO TREAT OSTEOARTHRITIS, RHEUMATOID DISEASE, ANKYLOSING SPONDYLITIS, MUSCULOSKELETAL DISORDERS, AND TRAUMA, INCLUDING PERIARTHRITIS, BURSITIS, FROZEN SHOULDER, TENDINITIS, LOW BACK PAIN, TENOSYNOVITIS, SPRAINS, AND STRAINS.

  • Musculoskeletal Disorder
  • World
  • Ampio Pharmaceuticals, Inc.
  • Novartis AG
  • Pfizer Inc.

Its R& D is focused on the following six therapeutic areas: endocrine diseases, cancer, autoimmune diseases, neurological disorders, musculoskeletal disorders, and cardiovascular diseases.

  • Musculoskeletal Disorder
  • Amgen Inc.
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novartis AG
  • Rheumatoid arthritis
  • recombinant hormone

INTRODUCTION With the rising trend towards self-injection devices and rapidly growing pipeline of the biologics / biosimilars, autoinjectors have recently emerged as an important class of medical devices. Compared to conventional delivery systems, these devices automate the process of delivering drugs through subcutaneous or...

  • Musculoskeletal Disorder
  • Vaccine
  • United States
  • Demand
  • Market Size
  • REFERENCES

Prevalence and impact of musculoskeletal disorders of the upper limb in the general population.

  • Arthritis
  • Chronic Disease
  • Epidemiology
  • Musculoskeletal Disorder
  • Forecast
  • REFERENCES

Prevalence and impact of musculoskeletal disorders of the upper limb in the general population.

  • Arthritis
  • Chronic Disease
  • Musculoskeletal Disorder
  • Pathology
  • United States
  • 12.1 INTRODUCTION

IN INDIA, ## PERCENT OF THE OVERALL POPULATION SUFFERS FROM AILMENTS RELATED TO MUSCULOSKELETAL DISORDERS (MSD).

  • Musculoskeletal Disorder
  • South America
  • Forecast
  • Market Size
  • Zimmer Biomet Holdings, Inc.

The data focuses on (##) arthropathies: e. g. infectious arthropathies; inflammatory polyarthropathies; arthrosis; systemic connective tissue disorders, (##) dorsopathies: e. g. deforming dorsopathies; spondylopathies, (##) soft tissue disorders: e. g. disorders of musc

  • Chronic Disease
  • Musculoskeletal Disorder
  • Pathology
  • Germany
  • REFERENCES

Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.

  • Arthritis
  • Chronic Disease
  • Musculoskeletal Disorder
  • Pathology
  • 8.2 MUSCULOSKELETAL DISORDERS
  • MUSCULOSKELETAL DISORDERS COMMANDS THE LARGEST SHARE OF THE

The global stem cell therapy market is estimated to grow at a CAGR of 11.0% during 2016 to 2021 to reach USD 145.8 million by 2021. Growth in the global stem cell therapy market is driven by factors such as the growing awareness of the therapeutic potency of stem cells in effective disease management, development of advanced genome-based cell...

  • Musculoskeletal Disorder
  • Stem Cell Therapy
  • North America
  • United States
  • MediPost Co., Ltd.

Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.

  • Chronic Disease
  • Epidemiology
  • Musculoskeletal Disorder
  • Pathology
  • Forecast
  • Proportion of Osteonecrosis to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2016*
  • Clinical Trials by G7 Countries: Proportion of Osteonecrosis to Musculoskeletal Disorders Clinical Trials

Osteonecrosis Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Osteonecrosis Global Clinical Trials Review, H1, 2018" provides an overview of Osteonecrosis clinical trials scenario.This report provides top line data relating to the clinical trials on Osteonecrosis. Report...

  • Drug Discovery And Development
  • Musculoskeletal Disorder
  • World
  • Product Initiative
  • Novartis AG
  • PROPORTION OF MUSCLE INJURY TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS, G7 COUNTRIES (%), 2018*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF MUSCLE INJURY TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS

Muscle Injury Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Muscle Injury Global Clinical Trials Review, H1, 2018" provides an overview of Muscle Injury clinical trials scenario.This report provides top line data relating to the clinical trials on Muscle Injury. Report...

  • Musculoskeletal Disorder
  • Therapy
  • World
  • Product Initiative
  • Pluristem Therapeutics Inc.
  • SMALL MOLECULES FOR METABOLIC AND MUSCULOSKELETAL DISORDERS - DRUG PROFILE
  • DRUGS TO MODULATE PPAR-DELTA FOR METABOLIC AND MUSCULOSKELETAL DISORDERS - DRUG PROFILE

Osteoarthritis - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Pipeline Review, H1 2018, provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape. Osteoarthritis (OA) is...

  • Arthritis
  • Cell Therapy
  • Musculoskeletal Disorder
  • Therapy
  • Amgen Inc.
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF MUSCLE SPASM TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS
  • PROPORTION OF MUSCLE SPASM TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS, G7 COUNTRIES (%), 2018*

Muscle Spasm Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Muscle Spasm Global Clinical Trials Review, H1, 2018" provides an overview of Muscle Spasm clinical trials scenario.This report provides top line data relating to the clinical trials on Muscle Spasm. Report...

  • Clinical Trial
  • Musculoskeletal Disorder
  • Pain Relief
  • World
  • Product Initiative
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF MUSCULAR DYSTROPHY TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS
  • PROPORTION OF MUSCULAR DYSTROPHY TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS, G7 COUNTRIES (%), 2018*

Muscular Dystrophy Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Muscular Dystrophy Global Clinical Trials Review, H1, 2018" provides an overview of Muscular Dystrophy clinical trials scenario.This report provides top line data relating to the clinical trials...

  • Musculoskeletal Disorder
  • Neurological Disorder
  • Therapy
  • World
  • Product Initiative
  • PROPORTION OF MUSCLE RELAXATION TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS, E7 COUNTRIES (%), 2018*
  • PROPORTION OF MUSCLE RELAXATION TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS, G7 COUNTRIES (%), 2018*

Muscle Relaxation Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Muscle Relaxation Global Clinical Trials Review, H1, 2018" provides an overview of Muscle Relaxation clinical trials scenario.This report provides top line data relating to the clinical trials on...

  • Musculoskeletal Disorder
  • Therapy
  • World
  • Product Initiative
  • Merck & Co., Inc.
  • SMALL MOLECULE TO INHIBIT BMP FOR CARDIOVASCULAR, CNS, ONCOLOGY AND MUSCULOSKELETAL DISORDERS - DRUG PROFILE
  • FIBRODYSPLASIA OSSIFICANS PROGRESSIVA (MYOSITIS OSSIFICANS PROGRESSIVA) - PIPELINE BY LA JOLLA PHARMACEUTICAL COMPANY, H2 2017

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Fibrodysplasia Ossificans Progressiva - Pipeline Review, H2 2017, provides an overview of the Fibrodysplasia...

  • Musculoskeletal Disorder
  • United States
  • World
  • Product Initiative
  • Clementia Pharmaceuticals Inc.